Home-Ultrasound in Routine High-Risk Care of Patients With Gestational Diabetes Mellitus (GDM)

ConditionGestational Diabetes Mellitus

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexFemale

Age18-51

SponsorWolfson Medical Center

About this trial

This study evaluates the impact of incorporating home-ultrasound (home-US) devices into telemedicine care for patients with gestational diabetes mellitus (GDM). The study will compare satisfaction, clinical outcomes, and healthcare costs between standard high-risk pregnancy care and care augmented by home-US.

Eligibility criteria

Qualifiers

Singleton pregnancy

GDM diagnosed by OGTT or glucose monitoring

Hebrew speaking

Compatible cellphone

Disqualifiers

Pregestational diabetes

Fetal anomalies/genetic abnormalities

Multifetal pregnancy

Late GDM diagnosis (after 34 weeks)

Trial design

Treatments tested in this trial

Use of the Pulsenmore home ultrasound device for fetal assessment, guided remotely by a physician.

Treatment groups

90 Participants

are divided into 2 treatment groups

Locations

Map coordinates are unavailable for these locations. Locations are shown below instead.

Edith Wolfson Medical CenterRecruiting5834468, H̱olon, Central District Israel

Israel

Sponsors and collaborators

Wolfson Medical Center

Lead sponsor

PulseNmore

Collaborator

Source ClinicalTrials.gov